DeepSeq.AI, Inc.
PrivateLast Round
Seed
Jan 12, 2026
Total Funding Raised
$849,797
Momentum
Top 10%
of companies Caplight tracks
Company Overview
DeepSeq.AI, Inc. is a biotechnology company that develops an AI-driven protein engineering platform to accelerate the discovery and optimization of biologics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DeepSeq.AI, Inc. Comparables
Compare DeepSeq.AI, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 310.ai | 87% | |
| Abiologics | 82% | |
| Nabla Bio | 80% |
DeepSeq.AI, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 12, 2026 | ||||
| Grant | May 21, 2025 | ||||
| Grant | Aug 19, 2024 | ||||
| Grant | Jul 15, 2024 | ||||
| Accelerator | Nov 1, 2023 |
DeepSeq.AI, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| McKesson Ventures | Accelerator |
| Berkeley SkyDeck | Accelerator |
| Northpond Ventures | Accelerator |
| ZAKA VC | Seed |
| Merck Digital Sciences Studio | Accelerator |
| National Science Foundation | Grant |
| Illumina Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 373% MoM, reaching 2.7K.
- May 5, 2026
CEO Andrew Chang to present at SynBioBeta conference on May 5, 2026.
DeepSeq.AI, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about DeepSeq.AI, Inc.'s valuation, stock price, and market status.
Is DeepSeq.AI, Inc. a public or private company?
DeepSeq.AI, Inc. is a private company.
What is the current stock price of DeepSeq.AI, Inc.?
DeepSeq.AI, Inc. is a private company, so its shares have no public market price. Caplight tracks DeepSeq.AI, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DeepSeq.AI, Inc. worth (valuation)?
Valuation information for DeepSeq.AI, Inc. is not publicly available.
Can I buy DeepSeq.AI, Inc. stock?
DeepSeq.AI, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DeepSeq.AI, Inc.'s last funding round?
DeepSeq.AI, Inc.'s most recent funding round was Seed on January 12, 2026.
Who are the main investors in DeepSeq.AI, Inc.?
Key investors in DeepSeq.AI, Inc. include ZAKA VC, Merck Digital Sciences Studio.
Will DeepSeq.AI, Inc. IPO soon?
No public IPO plans have been announced for DeepSeq.AI, Inc..
How can I track DeepSeq.AI, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in DeepSeq.AI, Inc.'s shares on secondary markets.